Life Sciences and Technology Lending
People - MidCap Financial Services, LLC*
William Gould is a co-founder of MidCap Financial and President of Asset Based and Life Sciences Lending. Prior to joining MidCap Financial, Mr. Gould created and ran the life sciences venture finance practice for Merrill Lynch Capital Healthcare Finance. Mr. Gould also served as a Team Leader responsible for underwriting asset based and specialty real estate loans at Merrill Lynch Capital. From 2001 to 2003, Mr. Gould was a Vice President at GE Capital’s Healthcare Commercial Finance business unit where he led the asset based underwriting group. Mr. Gould also spent four years in the corporate and securities group of the law firm of Hogan and Hartson. Mr. Gould holds a B.A. in Philosophy from Haverford College and a J.D. from the University of Virginia School of Law.
James Taylor is the Managing Director & Head of Life Sciences Finance. Prior to joining MidCap Financial, Mr. Taylor was the head of Silicon Valley Bank’s San Francisco lending team specializing in loans to biotech, medical devices and diagnostics companies. In this capacity, Mr. Taylor was responsible for expanding the Bank’s venture debt portfolio and servicing over 150 client relationships. Prior to joining Silicon Valley Bank, Mr. Taylor was a director of business development for the Export – Import Bank in Washington DC, responsible for business development in Virginia, Maryland, North Carolina and South Carolina. Mr. Taylor graduated from Hamilton College in Clinton, NY with a double major in history and French. In his spare time, James is an avid backcountry fly-fisherman and skier.
Michael Marziani was most recently a Managing Director & Head of Technology Venture Finance. Prior to joining Ares in 2012, Mr. Marziani was a Managing Director at BlueCrest Capital, where he focused on originating, structuring and negotiating investment opportunities. Mr. Marziani holds a B.S. from Fairfield University in Finance and an M.B.A. from the Northwestern University Kellogg School.
Colleen Kovas is an underwriter in MidCap Financial’s Life Sciences Lending group. Prior to joining MidCap Financial, Ms. Kovas was the Director of Portfolio Management at BlueCrest Capital Finance. Prior to that, Ms. Kovas was a member of the life sciences venture finance practice at Merrill Lynch Capital. Ms. Kovas began her career in corporate and financial public relations. Ms. Kovas holds a B.A., magna cum laude, in Government & International Studies from the University of Notre Dame.
Ross Hartman is a Director in MidCap Financial’s Life Science Lending group. Mr. Hartman has nearly a decade of experience providing debt financing to public and private companies. Prior to joining MidCap Financial, Mr. Hartman was a Senior Director at Oxford Finance where he was responsible for underwriting and portfolio management of life science venture loans. Prior to Oxford, Mr. Hartman was an Associate at MCG Capital, a middle market lender. Mr. Hartman holds a B.S. in Finance, summa cum laude, from Virginia Tech.
Nathan Rothschild is an underwriter in MidCap Financial’s Life Science and Asset Based Lending groups where he is responsible for structuring and executing senior financings. Mr. Rothschild has held various roles at MidCap Financial since 2012. He earned his Masters in Finance from the Owen Graduate School of Management at Vanderbilt University and a B.A. in Economics and Political Science, summa cum laude, from Vanderbilt University. He is a CFA charterholder.
Michael Guess joined MidCap Financial in 2014 and is a Director in the Life Sciences and Technology Lending group. He is responsible for originating, underwriting, and executing investments in public and venture-backed life sciences and technology companies. Prior to joining MidCap Financial, Michael was a member of KPMG’s Management Consulting practice where he advised life sciences companies on strategic and transformation initiatives. Mr. Guess holds a B.S. in Finance from the University of Illinois at Urbana-Champaign.
Josh Groman is currently Deputy Chief Investment Officer. Prior to joining MidCap Financial, Dr. Groman was head of underwriting for life science transactions at Merrill Lynch Capital Healthcare Finance. From 2004 to 2007, he served as an Engagement Manager in the life sciences consulting practice at Leerink Swann & Company where he advised biotech, pharmaceutical and device manufacturers on product strategy, business development and M&A due diligence. Dr. Groman holds a Ph.D. in Human Genetics and Molecular Biology from the Johns Hopkins School of Medicine and has published 11 research articles in leading scientific and medical journals. He also holds a B.S. from the State University of New York/Syracuse University and an M.S. in Biology from Vanderbilt University.
* See "Firm Overview" page for information on MidCap Financial's relationship with MidCap Financial Services, LLC and Apollo Capital Management, L.P.